You are here

Major shareholder announcement

Company Announcement
14 September 2018



Pursuant to section 30 of Consolidated Act no. 12 of 8 January 2018 on capital markets, as amended, NeuroSearch A/S ("NeuroSearch") hereby announces to have received a major shareholder announcement from Amici Capital, LLC, formerly known as Porter Orlin LLC.

Amici Capital, LLC, has informed NeuroSearch that by the latest major shareholder announcement of 16 December 2011 Amici Capital, LLC managed 2,481,804 shares corresponding to 10.11 percent of the shares and voting rights.

After a sale of shares on 8 September 2016 Amici Capital, LLC managed 2,382,404 shares and 47,648,080 voting rights corresponding to 9.70 percent of the shares and voting rights.

After a sale of shares on 24 January 2017 Amici Capital, LLC managed 1,000,000 shares and 20,000,000 voting rights corresponding to 4.07 percent of the shares and voting rights.

Amici Capital, LLC has subsequently disposed of its remaining shares in NeuroSearch and Amici Capital, LLC does not administer shares or voting rights in NeuroSearch.



Contact
Allan Andersen, CEO, mobile telephone 4016 3864.



About NeuroSearch
NeuroSearch A/S (NEUR) is listed on Nasdaq Copenhagen A/S.

Attachment

Friday, September 14, 2018 - 08:55

More Headlines

First Once-Daily, Nebulized Bronchodilator Available at End of 2018
AI Software Helps Physicians Prioritize Patients with Hemorrhagic Stroke or Intracranial Trauma
Empagliflozin Could Help Prevent Heart Disease and Heart Failure
Combination of Experimental Drug and Checkpoint Inhibitors Fight Tumor Cells
Zulresso May Alleviate Symptoms for Thousands of Women
Developed for Tumors Resistant to Other TKIs
New Drug Reduces Infection in Chemotherapy Patients
Daily Use of AHCC Supplement Could Support Immune System, Eliminate HPV
Unique Bio-Identical Hormone Therapy for Treatment of Hot Flashes